INSIGHTS ON CLINICAL TRIAL DESIGN
-
![Human Abuse Potential: Subjective Ratings]( "Human Abuse Potential: Subjective Ratings")
Human Abuse Potential: Subjective RatingsAccurate subjective ratings are central to Human Abuse Potential studies. Learn how Visual Analog Scales are administered, what influences responses, and why data collection practices are essential.
-
![GettyImages-1319939893-car-travel-road]( "Patient Centric Clinical Trials: Why Transportation Is A Timeline Risk")
Patient Centric Clinical Trials: Why Transportation Is A Timeline RiskAddress transportation barriers to reduce protocol deviations and data gaps. Strategies that lower travel burden protect study timelines and improve visit adherence for better trial outcomes.
-
![2020 in front of the mountains]( "FDA Fast-Tracked Clinical Trial")
FDA Fast-Tracked Clinical TrialDeconstruct the enrollment bottleneck in an ophthalmic gene therapy trial, discovering how point-of-need pre-screening cuts site activation delays and accelerates clinical development timelines.
-
![GettyImages-2200128716-software-ai-machine-learning-percentages-code]( "Streamlining The Clinical Trial Workflow From Protocol Design To Regulatory Submission")
Streamlining The Clinical Trial Workflow From Protocol Design To Regulatory SubmissionLearn how to create a direct line from clinical planning and protocol design to clinical trial disclosure to optimize efficiency across the entire trial lifecycle.
-
The Impact Of GLP-1s On Cardiovascular Clinical Development7/23/2026
As GLP-1 use expands, cardiovascular research is evolving. Discover key trial design considerations, development trends, and insights driving cardiometabolic innovation.
-
Linking Neurology And Ophthalmology For Clinical Trials1/22/2025
Learn more about the innovative approach being taken to incorporate ophthalmology into neurology and central nervous system (CNS) research.
-
Early Detection vs. Overdiagnosis: The ctDNA Screening Paradox6/4/2026
Discover how ctDNA could transform early cancer detection and why the BRCA model offers important lessons for balancing innovation, risk, and meaningful patient outcomes.
-
Decentralized Clinical Trials: FDA Guidance Analyzed2/11/2025
Explore the evolution of the FDA decentralized clinical trial (DCT) guidance, highlighting key updates on responsibilities, data variability, inspections, and trial design.
-
Why Specialty Lab Samples Are So Vulnerable To Trial Execution Errors7/17/2026
Biomarkers and other specialty lab samples are among the most fragile parts of clinical trial execution, but what makes them so vulnerable to mishandling, and what are the effects?
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-186481201 doctor patient]( "Ethnobridging: Clinical Research Capabilities")
Altasciences recruits from a large ethnic population in Southern California and have a dedicated Asian recruitment and outreach department to liaise with our participants.
-
![GettyImages-904483784 doctor patient]( "Clinical Trial Site Selection And Management")
Our network of 150+ active clinical trial sites allows us to identify potential partners that align with your therapeutic area, geographic preference, and specialty population requirements.
-
![GettyImages-966826582 data, research, analytics]( "Drive Patient Enrollments With Data-Powered Recruitment Engine")
Generate consistent, successful clinical trial recruitment on repeat with Citeline Connect's multifaceted approach to patient engagement and recruitment.
-
![GettyImages-2161842577-business-professional-laptop-office-table]( "Overcome Biosafety Challenges With An Innovative IBC")
Simplify biosafety oversight and accelerate study startup with expert guidance that ensures NIH compliance while protecting researchers, communities, and the environment.
-
![GettyImages-1403159350 patient experience]( "Educate, Engage, Enroll: Accelerating Patient Recruitment")
Built on a globally compliant platform, explore a suite of technologies and services that sits at the crossroads of sponsors, recruitment partners, patients, HCPs, and trial sites.
